Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News

August 27, 2015
Gilead Applies for PrEP Approval in Canada
Gilead Sciences has applied for approval of Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) in Canada.
August 26, 2015
Highest-Risk Gay and Bi Men Likeliest to Join Brazilian PrEP Study
A study of PrEP among Brazilian transgender women and gay and bi men has found that those at highest risk of HIV were the most likely to participate.
August 25, 2015
Monkeys Have Had HIV-Like Viruses for Millions of Years
Lentiviruses, the class of viruses to which HIV belongs, are estimated to have infected primates as far back as 16 million years ago.
August 24, 2015
Are HIV Docs Testing Enough for Hep B-Linked Liver Cancer?
HIV specialists may be much less likely than hepatologists to screen for hepatocellular carcinoma (HCC, the most common form of liver cancer) among those with hepatitis B.
Cure Hep C and You May See Your Liver Health Improve
Among those coinfected with HIV, a cure for hepatitis C is linked with improvements in liver stiffness, even if they have cirrhosis.
August 21, 2015
Skipping HIV Meds While Abusing Drugs? Think Again
Mistakenly believing that antiretrovirals and illicit drugs are a toxic mix, many people with HIV intentionally skip their ARVs when they plan to use such substances.
August 20, 2015
Ontario’s HIV Population Nears UN Care and Viral Suppression Targets
The rates of people living with HIV in Ontario, Canada, who are in medical care and who have an undetectable viral load are nearing United Nations targets for what it would take to send the HIV epidemic into a significant retreat.
August 19, 2015
Children Who Contracted HIV at Birth May Lack Measles Immunity
Youths who contracted HIV at birth may lack immunity to measles, mumps and rubella despite vaccination for the three diseases.
Liver Biopsies Miss 75% of Hep C-Related Cirrhosis Cases
Relying solely on a liver biopsy to diagnose cirrhosis among people with hepatitis C likely misses three in four cases of the advanced stage of liver disease.
August 18, 2015
AIDS Healthcare Foundation Cedes Ground in Anti-PrEP Fight
AIDS Healthcare Foundation, which has long waged a vociferous and largely isolated battle against Truvada as PrEP, has finally begun to capitulate, offering measured support for the HIV prevention method.
August 17, 2015
Hepatitis C May Hurt the Heart in Addition to the Liver
Hepatitis C is linked with plaque buildup in the arteries, a precursor to cardiovascular disease.
PrEP Is Safe for People With Hepatitis B
People with hepatitis B can safely take Truvada  as PrEP, as it does not lead to liver inflammation “flares” or other health problems when it is used or discontinued.
August 14, 2015
Response to the Indiana HIV/Hep C Outbreak Is a Test Case
There are lessons to learn from the response to the injection drug use-related outbreak of HIV and hepatitis C in rural Indiana.
August 13, 2015
Weekly Injectable HIV Antibody Treatment Shows Promise
A weekly injection of an HIV antibody boasted a 98 percent success rate among participants in a small trial.
August 12, 2015
Best Birth Control for Women With HIV: Implants, Injectables
The most effective birth control methods for women with HIV are implants and injectable hormonal contraceptives.
August 10, 2015
Affordable Care Act Is a Success On Many Counts
The Affordable Care Act has succeeded in reducing the uninsured rate, improving access to physicians and medications, and making health care more affordable.
New Hep C Drugs Cure High Rates of People Coinfected With HIV
In recent trials Harvoni, Viekira Pak and grazoprevir/elbasvir all cured high rates of hepatitis C among those coinfected with HIV.
August 07, 2015
Teen Sex, Pregnancy and Birth Rates Steadily Drop
Today’s teenagers are less likely to have had sex than those from a generation before.
August 06, 2015
Why One HIV Vaccine Failed
One of the HIV vaccines tested in clinical trials may have failed because it spurred not just antibodies active against the virus but gut bacteria as well.
August 05, 2015
Rectal Gonorrhea and Chlamydia Don’t Help HIV Transmission
Among people with HIV, chlamydia and gonorrhea infections in the rectum do not influence the likelihood of transmitting the virus to others.
Daklinza/Sovaldi Success for Those With HIV/HCV
A look at real-world use of Bristol-Myers Squibb’s Daklinza (daclatasvir) and Gilead Sciences’ Sovaldi (sofosbuvir) showed that, among those coinfected with HIV, the combination treats hepatitis C virus (HCV) just as well as in clinical trials
August 04, 2015
Treating HIV and Addiction Together Packs a Life-Saving Punch
Providing both opioid substitution therapy and antiretrovirals to HIV-positive injection drug users saves more lives than giving just one of the therapies.
August 03, 2015
Peer Intervention Cuts HIV Risk in Ukrainian IDUs
A program of peer-based education reduced HIV incidence among injection drug users in Ukraine, apparently because of greater use of needle exchange programs.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Should sex work be legalized?

Are You Undetectable?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.